| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/10/2013 | CN101318017B Vaccine for preventing and/or treating allergic asthma |
| 04/09/2013 | US8415525 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 04/09/2013 | US8415460 Methods of making antibodies specific for cysteine-rich soluble protein C23 |
| 04/09/2013 | US8415317 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 04/09/2013 | US8415306 Insulin-like growth factor 1 receptor binding peptides |
| 04/09/2013 | US8415303 Method of treatment using a soluble human delta protein fragment |
| 04/09/2013 | US8415152 Therapeutical composition containing dentritic cells and use thereof |
| 04/09/2013 | US8415132 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines |
| 04/09/2013 | US8414947 Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter |
| 04/09/2013 | US8414903 Escherichia coli mutants and methods of use thereof |
| 04/09/2013 | US8414902 Method for treating depression |
| 04/09/2013 | US8414901 Canine Lyme disease vaccine |
| 04/09/2013 | US8414900 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 04/09/2013 | US8414899 Vaccines comprising multimeric HSP60 peptide carriers |
| 04/09/2013 | US8414898 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/09/2013 | US8414897 Pathway for Th-17 cell development and methods utilizing same |
| 04/09/2013 | US8414896 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | US8414893 Anti-amyloid antibodies and uses thereof |
| 04/09/2013 | US8414892 Uses of monoclonal antibody 8H9 |
| 04/09/2013 | US8414891 Method for treating pulmonary hypertension |
| 04/09/2013 | US8414890 Human antibodies to human RANKL, encoding nucleic acids and methods of treatment |
| 04/09/2013 | US8414889 Protective anti-glucan antibodies with preference for β-1,3-glucans |
| 04/09/2013 | US8414888 Therapeutic use of IgG as a neuroprotective agent |
| 04/09/2013 | US8414887 Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists |
| 04/09/2013 | US8414886 Method of treating disease |
| 04/09/2013 | US8414885 Methods and compositions for treating cancer |
| 04/09/2013 | US8414884 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
| 04/09/2013 | US8414878 Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein |
| 04/09/2013 | US8414865 Use of Mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis |
| 04/09/2013 | CA2562771C Anti-il-9 antibody formulations and uses thereof |
| 04/09/2013 | CA2546406C Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 04/09/2013 | CA2486618C Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 04/09/2013 | CA2398269C Non-immunosuppressant hiv tat |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/09/2013 | CA2361658C T helper cell epitopes |
| 04/09/2013 | CA2241373C Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 04/04/2013 | WO2013049535A2 Influenza vaccine |
| 04/04/2013 | WO2013049517A2 Therapeutic peptides |
| 04/04/2013 | WO2013049342A1 Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus |
| 04/04/2013 | WO2013049294A1 2-hydroxyhippuric acid analogs, and methods for their synthesis and use |
| 04/04/2013 | WO2013049278A1 USE OF IL-1 ß BINDING ANTIBODIES |
| 04/04/2013 | WO2013049254A1 Hybrid constant regions |
| 04/04/2013 | WO2013048883A2 Anti-erbb3 antibodies and uses thereof |
| 04/04/2013 | WO2013048345A1 Methods and pharmaceutical compositions for treating cancer |
| 04/04/2013 | WO2013047752A1 Antigen-binding molecule for promoting loss of antigens |
| 04/04/2013 | WO2013047748A1 Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities |
| 04/04/2013 | WO2013047745A1 Oral composition |
| 04/04/2013 | WO2013047729A1 Antigen-binding molecule inducing immune response to target antigen |
| 04/04/2013 | WO2013046722A1 Ion concentration-dependent binding molecule library |
| 04/04/2013 | WO2013045707A2 Biological materials related to c-met |
| 04/04/2013 | WO2013045668A2 Immunotherapy composition and regimen for treating hepatitis c virus infection |
| 04/04/2013 | WO2013045658A1 Immunotherapy composition and regimen for treating hepatitis c virus infection |
| 04/04/2013 | WO2013045580A1 Anti-icam-1 antibodies to treat multiple-myeloma related disorders |
| 04/04/2013 | WO2013045469A1 Igy composition for use in coeliac disease |
| 04/04/2013 | WO2013044840A1 Neutralizing molecule of highly pathogenic avian influenza and preparation method therefor |
| 04/04/2013 | WO2013044419A1 Combined facilitator, antigen and dna vaccine for preventing and treating autoimmune diseases |
| 04/04/2013 | WO2013044398A1 Chlamydia antigen compositions and uses thereof |
| 04/04/2013 | WO2013044390A1 Increasing virus-like particle yield in plants |
| 04/04/2013 | WO2013044298A1 Antibodies against tl1a and uses thereof |
| 04/04/2013 | WO2013023059A3 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
| 04/04/2013 | WO2013023015A3 Targets for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes |
| 04/04/2013 | WO2013020722A3 Composition comprising small peptide as amyloid beta mimotope and adjuvant for use as vaccine against alzheimer's disease |
| 04/04/2013 | WO2013019620A3 Method of treating cancer using combination of braf inhibitor, mek inhibitor, and anti-ctla-4 antibody |
| 04/04/2013 | WO2013015586A9 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry |
| 04/04/2013 | WO2013012683A3 Gel vaccine delivery system for treating poultry |
| 04/04/2013 | WO2013006688A3 N-terminal deleted gp120 immunogens |
| 04/04/2013 | WO2013006401A3 Methods and compositions of protein antigens for the diagnosis and treatment of herpes simplex viruses type 1 and 2 |
| 04/04/2013 | WO2013004842A3 Antibody variants and uses thereof |
| 04/04/2013 | WO2013003583A3 Somatic mutations in atrx in brain cancer |
| 04/04/2013 | WO2012177520A3 Oligopeptides and their use for treating infectious diseases |
| 04/04/2013 | WO2012170742A3 Treatment and prevention of cancer with hmgb1 antagonists |
| 04/04/2013 | WO2012170097A3 Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus |
| 04/04/2013 | WO2012138694A3 Compositions comprising saccharide binding moieties and methods for targeted therapy |
| 04/04/2013 | WO2012128799A3 Treating schizophrenia |
| 04/04/2013 | WO2012109314A3 Potent hiv inhibitors targeting ccr5 and gp41 |
| 04/04/2013 | WO2012074842A3 Compositions and methods for treating neoplasia |
| 04/04/2013 | WO2011150264A3 Synthetic nanocarrier combination vaccines |
| 04/04/2013 | US20130085262 Novel surface antigen |
| 04/04/2013 | US20130084309 Process for the preparation of o/w emulsion |
| 04/04/2013 | US20130084308 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 04/04/2013 | US20130084307 Vaccine composition containing synthetic adjuvant |
| 04/04/2013 | US20130084306 Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules |
| 04/04/2013 | US20130084303 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| 04/04/2013 | US20130084301 Cluster of Neutralizing Antibodies to Hepatitis C Virus |
| 04/04/2013 | US20130084300 Diagnosis and prevention of cancer cell invasion |
| 04/04/2013 | US20130084299 Methods |
| 04/04/2013 | US20130084298 Novel anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof |
| 04/04/2013 | US20130084297 Anti-ErbB3 Antibodies and Uses Thereof |
| 04/04/2013 | US20130084296 Modulation of srpx2-mediated angiogenesis |
| 04/04/2013 | US20130084295 Anti-interferon-alpha antibodies |
| 04/04/2013 | US20130084294 Anti-cd19 antibodies and uses in b cell disorders |
| 04/04/2013 | US20130084293 Histamine-releasing factor (hrf), hrf-receptor and methods of modulating inflammation |
| 04/04/2013 | US20130084292 Antagonists for the Prevention of Treatment of Inflammatory Bowel Disease, and More Particularly of Crohn's Disease |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | US20130084280 Compositions including triciribine and methods of use thereof |
| 04/04/2013 | US20130084279 Compositions including triciribine and trastuzumab and methods of use thereof |
| 04/04/2013 | DE102008060614B4 Verfahren zur Herstellung einer Inhalationsatmosphäre für die Allergenprovokation Process for the preparation of an inhalation atmosphere for allergen challenge |
| 04/04/2013 | CA2850720A1 Binding molecule having influenza a virus-neutralizing activity produced from human b cell |